TMThomas Charles Mutter

Thomas Charles Mutter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Charles Mutter has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Postoperative vision loss and visual disturbances in a Canadian provincial administrative data repository

    by Michael T. Paillé, Frank Stockl, Thomas C. Mutter

    Purpose Population-based, health administrative database analyses of postoperative vision loss (POVL) have primarily examined International Classification of Diseases (ICD) diagnosis codes for ischemic optic neuropathy (ION) and retinal artery occlusion (RAO) after cardiac and spine surgery. Other nonspecific diagnosis codes describing significant vision loss have been mostly overlooked. We sought to investigate their contribution to the broader epidemiology of POVL after a variety of surgical procedures. Methods Using administrative data from Manitoba, Canada, we identified hospital admissions where patients underwent spine, cardiac, and other common inpatient and ambulatory surgeries between 1987 and 2017. To avoid misclassifying pre-existing vision loss as POVL, we excluded admissions where patients had ICD diagnosis codes suggestive of pre-existing vision loss in at least 5 years of preoperative data. Postoperative vision loss outcomes included specific diagnosis codes, such as RAO and ION, and nonspecific diagnosis codes for blindness, visual disturbances, and visual field defects. Results We excluded 158,730 admissions for suspected pre-existing vision loss, including 345 admissions with POVL diagnosis codes. We included 170 POVL cases in 596,241 admissions. Nonspecific diagnosis codes accounted for 140 (82%) cases and were associated with risk factors previously reported for ION, RAO, and cortical blindness. Overall, 24 (14%) cases were RAOs, and privacy restrictions precluded analysis of the remaining 6 (4%) cases. The incidence of RAO and nonspecific diagnosis codes was highest after cardiac and spine surgery. Still, other types of surgery accounted for 87 (62%) of the nonspecific diagnosis code cases and 11 (46%) of the RAO cases. Conclusion In surgical patients without a history of vision loss, new diagnosis codes for blindness, visual field defects, and visual disturbances other than ION and RAO may represent an important but overlooked aspect of POVL epidemiology.


  • Response to Fu and Zheng regarding: “The effect of intravenous tranexamic acid on visual clarity in arthroscopic shoulder surgery compared to epinephrine and a placebo: a double-blinded, randomized controlled trial”

    by Thomas Suter, Sheila McRae, Yiyang Zhang, Peter B. MacDonald, Jarret M. Woodmass, Thomas C. Mutter, Scott Wolfe, Jonathan Marsh, Jamie Dubberley, Jason Old

  • Open Access

    An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial

    by Renée El-Gabalawy, Jordana L Sommer, Pamela Hebbard, Kristin Reynolds, Gabrielle S Logan, Michael S D Smith, Thomas C Mutter, W Alan Mutch, Natalie Mota, Catherine Proulx, et al.

    Background: Preoperative state anxiety (PSA) is distress and anxiety directly associated with perioperative events. PSA is associated with negative postoperative outcomes such as longer hospital length of stay, increased pain and opioid use, and higher rates of rehospitalization. Psychological prehabilitation, such as education, exposure to hospital environments, and relaxation strategies, has been shown to mitigate PSA; however, there are limited skilled personnel to deliver such interventions in clinical practice. Immersive virtual reality (VR) has the potential for greater accessibility and enhanced integration into an immersive and interactive experience. VR is rarely used in the preoperative setting, but similar forms of stress inoculation training involving exposure to stressful events have improved psychological preparation in contexts such as military deployment. Objective: This study seeks to develop and investigate a targeted PSA intervention in patients undergoing oncological surgery using a single preoperative VR exposure. The primary objectives are to (1) develop a novel VR program for patients undergoing oncological surgery with general anesthesia; (2) assess the feasibility, including acceptability, of a single exposure to this intervention; (3) assess the feasibility, including acceptability, of outcome measures of PSA; and (4) use these results to refine the VR content and outcome measures for a larger trial. A secondary objective is to preliminarily assess the clinical utility of the intervention for PSA. Methods: This study comprises 3 phases. Phase 1 (completed) involved the development of a VR prototype targeting PSA, using multidisciplinary iterative input. Phase 2 (data collection completed) involves examining the feasibility aspects of the VR intervention. This randomized feasibility trial involves assessing the novel VR preoperative intervention compared to a VR control (ie, nature trek) condition and a treatment-as-usual group among patients undergoing breast cancer surgery. Phase 3 will involve refining the prototype based on feasibility findings and input from people with lived experience for a future clinical trial, using focus groups with participants from phase 2. Results: This study was funded in March 2019. Phase 1 was completed in April 2020. Phase 2 data collection was completed in January 2024 and data analysis is ongoing. Focus groups were completed in February 2024. Both the feasibility study and focus groups will contribute to further refinement of the initial VR prototype (phase 3), with the final simulation to be completed by mid-2024. Conclusions: The findings from this work will contribute to the limited body of research examining feasible and broadly accessible interventions for PSA. Knowledge gained from this research will contribute to the final development of a novel VR intervention to be tested in a large population of patients with cancer before surgery in a randomized clinical trial. Trial Registration: ClinicalTrials.gov NCT04544618; https://www.clinicaltrials.gov/study/NCT04544618 International Registered Report Identifier (IRRID): DERR1-10.2196/55692


  • Open Access

    An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial (Preprint)

    by Renée El-Gabalawy, Jordana L Sommer, Pamela Hebbard, Kristin Reynolds, Gabrielle S Logan, Michael S D Smith, Thomas C Mutter, W Alan Mutch, Natalie Mota, Catherine Proulx, et al.

    BACKGROUND Preoperative state anxiety (PSA) is distress and anxiety directly associated with perioperative events. PSA is associated with negative postoperative outcomes such as longer hospital length of stay, increased pain and opioid use, and higher rates of rehospitalization. Psychological prehabilitation, such as education, exposure to hospital environments, and relaxation strategies, has been shown to mitigate PSA; however, there are limited skilled personnel to deliver such interventions in clinical practice. Immersive virtual reality (VR) has the potential for greater accessibility and enhanced integration into an immersive and interactive experience. VR is rarely used in the preoperative setting, but similar forms of stress inoculation training involving exposure to stressful events have improved psychological preparation in contexts such as military deployment. OBJECTIVE This study seeks to develop and investigate a targeted PSA intervention in patients undergoing oncological surgery using a single preoperative VR exposure. The primary objectives are to (1) develop a novel VR program for patients undergoing oncological surgery with general anesthesia; (2) assess the feasibility, including acceptability, of a single exposure to this intervention; (3) assess the feasibility, including acceptability, of outcome measures of PSA; and (4) use these results to refine the VR content and outcome measures for a larger trial. A secondary objective is to preliminarily assess the clinical utility of the intervention for PSA. METHODS This study comprises 3 phases. Phase 1 (completed) involved the development of a VR prototype targeting PSA, using multidisciplinary iterative input. Phase 2 (data collection completed) involves examining the feasibility aspects of the VR intervention. This randomized feasibility trial involves assessing the novel VR preoperative intervention compared to a VR control (ie, nature trek) condition and a treatment-as-usual group among patients undergoing breast cancer surgery. Phase 3 will involve refining the prototype based on feasibility findings and input from people with lived experience for a future clinical trial, using focus groups with participants from phase 2. RESULTS This study was funded in March 2019. Phase 1 was completed in April 2020. Phase 2 data collection was completed in January 2024 and data analysis is ongoing. Focus groups were completed in February 2024. Both the feasibility study and focus groups will contribute to further refinement of the initial VR prototype (phase 3), with the final simulation to be completed by mid-2024. CONCLUSIONS The findings from this work will contribute to the limited body of research examining feasible and broadly accessible interventions for PSA. Knowledge gained from this research will contribute to the final development of a novel VR intervention to be tested in a large population of patients with cancer before surgery in a randomized clinical trial. CLINICALTRIAL ClinicalTrials.gov NCT04544618; https://www.clinicaltrials.gov/study/NCT04544618 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/55692

  • The effect of intravenous tranexamic acid on visual clarity in arthroscopic shoulder surgery compared to epinephrine and a placebo: a double-blinded, randomized controlled trial

    by Thomas Suter, Sheila McRae, Yiyang Zhang, Peter B. MacDonald, Jarret M. Woodmass, Thomas C. Mutter, Scott Wolfe, Jonathan Marsh, Jamie Dubberley, Jason Old


  • Postoperative neurological symptoms following arthroscopic shoulder surgery with interscalene block: an exploratory secondary analysis of pooled randomized controlled trial data

    by Samantha Frost, Daniel Rodrigues, Ryan J J Amadeo, Scott Wolfe, Faylene Funk, Celeste Ferguson, Holly Brown, Peter MacDonald, Brenden Dufault, Thomas Charles Mutter

    Objective Postoperative neurological symptoms (PONS) are recognized complications of regional anesthesia and orthopedic surgery. We aimed to better characterize prevalence and potential risk factors in a homogeneous population of randomized, controlled trial participants. Methods Data were pooled from two randomized controlled trials of analgesia after interscalene block with perineural or intravenous adjuvants (NCT02426736, NCT03270033). Participants were at least 18 years of age and undergoing arthroscopic shoulder surgery at a single ambulatory surgical center. PONS were assessed by telephone follow-up at 14 days and 6 months postoperatively, and defined as patient report of numbness, weakness, or tingling in the surgical limb, alone or in combination, and regardless of severity or etiology. Results At 14 days, PONS occurred in 83 of 477 patients (17.4%). Among these 83 patients, 10 (12.0%) continued to have symptoms a half-year after surgery. In exploratory univariate analyses, no patient, surgical or anesthetic characteristics were significantly associated with 14-day PONS except for lower postoperative day 1 Quality of Recovery-15 questionnaire total score (OR 0.97 (95% CI, 0.96 to 0.99), pConclusion PONS are common after arthroscopic shoulder surgery performed with single injection ultrasound-guided interscalene blocks. No definitive mitigating risk factors were identified.


  • Open Access

    Benchmarking a Canadian anesthesiology resident research program against national norms using a logic model framework: a quality improvement study.

    by Erin Barbour-Tuck, Thomas Mutter, Jennifer M O'BRien, Linda Girling, Eugene Choo, Jonathan Gamble

    Background: Canadian specialty training programs are expected to deliver curriculum content and assess competencies related to the CanMEDS Scholar role. We evaluated our residency research program and benchmarked it against national norms for quality improvement purposes. Methods: In 2021, we reviewed departmental curriculum documents and surveyed current and recently graduated residents. We applied a logic model framework to assess if our program’s inputs, activities, and outputs addressed the relevant CanMeds Scholar competencies. We then descriptively benchmarked our results against a 2021 environmental scan of Canadian anesthesiology resident research programs. Results: Local program content was successfully mapped to competencies. The local survey response rate was 40/55 (73%). In benchmarking, our program excelled in providing milestone-related assessments, research funding, administrative, supervisory, and methodologic support, and requiring a literature review, proposal presentation, and local abstract submission as output. Acceptable activities to meet research requirements vary greatly among programs. Balancing competing clinical and research responsibilities was a frequently reported challenge. Conclusions: The logic model framework was easily applied and demonstrated our program benchmarked well against national norms. National level dialogue is needed to develop specific, consistent scholar role activities and competency assessments to bridge the gap between expected outcome standards and education practice.


  • Postoperative neurologic symptoms in the operative arm after shoulder surgery with interscalene blockade: a systematic review

    by Thomas Mutter, Gabrielle S. Logan, Sam Neily, Scott Richardson, Nicole Askin, Marita Monterola, Ahmed Abou-Setta

    Objective Postoperative neurologic symptoms (PONS) in the operative arm are important complications of shoulder surgery and interscalene blockade (ISB). This systematic review aimed to compare the risk of PONS between ISB and other techniques, and the relative safety of different agents used in ISB. Methods Our systematic review followed Cochrane review methodology and was registered in PROSPERO. A search of MEDLINE (Ovid), EMBASE (Ovid), and CENTRAL (Wiley) from inception to June 2020 was completed. We included randomized or quasi-randomized trials of patients (> five years old) undergoing shoulder surgery with any ISB technique as an intervention, compared with any other nonregional or regional technique, or ISB of alternate composition or technique. The primary outcome was PONS (study author defined) assessed a minimum of one week after surgery. Results Fifty-five studies totalling 6,236 participants (median, 69; range, 30–910) were included. Another 422 otherwise eligible trials were excluded because PONS was not reported. Heterogeneity in when PONS was assessed (from one week to one year) and the diagnostic criteria used precluded quantitative meta-analysis. The most common PONS definition, consisting of one or more of paresthesia, sensory deficit, or motor deficit, was only used in 16/55 (29%) trials. Risk of bias was low in 5/55 (9%) trials and high in 36/55 (65%) trials, further limiting any inferences. Conclusion These findings highlight the need for a standardized PONS outcome definition and follow-up time, along with routine, rigorous measurement of PONS in trials of ISB. Study registration PROSPERO (CRD42020148496); registered 10 February 2020.


  • Analgesic duration of interscalene block after outpatient arthroscopic shoulder surgery with intravenous dexamethasone, intravenous dexmedetomidine, or their combination: a randomized-controlled trial

    by Daniel Rodrigues, Ryan J. J. Amadeo, Scott Wolfe, Linda Girling, Faylene Funk, Kelsi Fidler, Holly Brown, Jeff Leiter, Jason Old, Peter MacDonald, et al.

    Purpose Both intravenous dexamethasone and dexmedetomidine prolong the analgesic duration of interscalene blocks (ISB) after arthroscopic shoulder surgery. This study compared their relative effectiveness and the benefit of their use in combination. Methods This single-centre, double-blinded, parallel three-group superiority trial randomized 198 adult patients undergoing ambulatory arthroscopic shoulder surgery. Patients received preoperative ISB with 30 mL 0.5% bupivacaine and 50 µg dexmedetomidine or 4 mg dexamethasone or both of these agents as intravenous adjuncts. The primary outcome was analgesic block duration. Secondary outcomes included the quality of recovery 15 score (range: 0–150) on day 1 and postoperative neurologic symptoms in the surgical arm. Results Block durations (n = 195) with dexamethasone (median [range], 24.5 [2.0–339.5] hr) and both adjuncts (24.0 [1.5-157.0] hr) were prolonged compared with dexmedetomidine (16.0 [1.5–154.0] hr). When analyzed by linear regression after an unplanned log transformation because of right-skewed data, the corresponding prolongations of block duration were 59% (95% confidence interval [CI], 28 to 97) and 46% (95% CI, 18 to 80), respectively (both P < 0.001). The combined adjuncts were not superior to dexamethasone alone (-8%; 95% CI, -26 to 14; P = 0.42). Median [IQR] quality of recovery 15 scores (n = 197) were significantly different only between dexamethasone (126 [79–149]) and dexmedetomidine (118.5 [41–150], P = 0.004), but by an amount less than the 8-point minimum clinically important difference. Conclusion Dexamethasone is superior to dexmedetomidine as an intravenous adjunct for prolongation of bupivacaine-based ISB analgesic duration. There was no additional benefit to using both adjuncts in combination. Trial registration www.clinicaltrials.gov (NCT03270033); registered 1 September 2017.


  • Does eliminating the preoperative history and physical make a difference in low-risk cataract surgery patients? A before and after study of 30-day morbidity and mortality

    by Archie Benoit, Lorne Bellan, Marc Wallace, Gillian Toth, Ruzica (Rose) Djukic, Barbara Ginter-Boyce, Linda Girling, Caroline Dekeyster, Thomas C. Mutter